Autolus Ltd.

📍 London, United Kingdom🗓 Founded 2014👥 416 employees💰 Last funded Sep 2017
Biotechnology🌐 autolus.com
Website LinkedIn
Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the Company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2014
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in Autolus Ltd.?
Autolus Ltd. has 1 investors on record on gritt.io, 1 mid-stage.
When did Autolus Ltd. last raise funding?
The most recent investment in Autolus Ltd. recorded on gritt.io was in September 2017.
When was Autolus Ltd. founded?
Autolus Ltd. was founded in 2014.
What industry is Autolus Ltd. in?
Autolus Ltd. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Autolus Ltd. based?
Autolus Ltd. is headquartered in London, United Kingdom.